UBS Group
THTX

UBS Group’s Theratechnologies THTX Stock Holding History

UBS Group’s Portfolio THTX Stock Details THTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,971
Closed -$21.2K – 10925
2025
Q2 		$21.2K Buy
8,971
+6,695
+294% +$16.4K ﹤0.01% 8388
2025
Q1 		$3.19K Buy
2,276
+527
+30% +$880 ﹤0.01% 9240
2024
Q4 		$3.17K Sell
1,749
-943
-35% -$1.28K ﹤0.01% 8921
2024
Q3 		$3.34K Sell
2,692
-14,846
-85% -$20.1K ﹤0.01% 8282
2024
Q2 		$24.6K Sell
17,538
-1,756
-9% -$2.33K ﹤0.01% 7172
2024
Q1 		$32K Buy
19,294
+811
+4% +$1.3K ﹤0.01% 6710
2023
Q4 		$29.9K Buy
18,483
+2,575
+16% +$3.88K ﹤0.01% 6847
2023
Q3 		$34.2K Buy
+15,908
New +$34.1K ﹤0.01% 6524

Other funds holding THTX

JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CWP
Cyndeo Wealth Partners St. Petersburg, Florida $1.9B AUM 24.89% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIP
Greatmark Investment Partners Columbus, Georgia $854M AUM 15.72% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM

UBS Group's THTX Position: Q3 2025 in Review

UBS Group sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 8,971 shares — an estimated $21.2K sold.

UBS Group first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $34.2K in Q3 2023. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • UBS Group reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • UBS Group sold 8,971 Theratechnologies shares in Q3 2025, an estimated $21.2K.
  • UBS Group first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • UBS Group's Theratechnologies position peaked at $34.2K in Q3 2023.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on UBS Group's 13F filing for Q3 2025, filed 13 Nov 2025.